Literature DB >> 8442693

Acute thrombosis of the splanchnic veins.

P Gertsch1, J Matthews, J Lerut, P Luder, L H Blumgart.   

Abstract

The consequence of an acute thrombosis in the splanchnic veins on the viability of the intestine has not been well defined in the literature. Spontaneous recovery or total necrosis of the bowel have both been described. We treated seven patients with thrombosis of the splanchnic veins and adopted a surgical approach in three patients with extended and complete thrombosis of the superior mesenteric vein, portal vein, and splenic vein, while four patients with partial thrombosis of the superior mesenteric vein or protal vein recovered with conservative treatment. A 22-year literature review has identified 64 cases of acute thrombosis in the splanchnic veins, with complete information regarding the location and extent of the thrombosis, the treatment, and the outcome. Different anatomical patterns of thrombosis with mortality rates varying between 0% and 76% seem to be related to the extent and completeness of venous obstruction.

Entities:  

Mesh:

Year:  1993        PMID: 8442693     DOI: 10.1001/archsurg.1993.01420150101018

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  9 in total

1.  Splanchnic venous thrombosis driven by a constitutively activated JAK2 V617F philadelphia-negative myeloproliferative neoplasm: a case report.

Authors:  Musa Waiswa; Emmanuel Seremba; Ponsiana Ocama; Henry Ddungu; Keneth Opio; Clement Okello; Timothy O'shea; Madeleine Verhovsek; Richard Mutyabule
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

2.  High incidence of thrombosis of the portal venous system after laparoscopic splenectomy: a prospective study with contrast-enhanced CT scan.

Authors:  Masataka Ikeda; Mitsugu Sekimoto; Shuji Takiguchi; Masaru Kubota; Masakazu Ikenaga; Hirofumi Yamamoto; Yoshiyuki Fujiwara; Masayuki Ohue; Takushi Yasuda; Hiroshi Imamura; Masayuki Tatsuta; Masahiko Yano; Hiroshi Furukawa; Morito Monden
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

3.  [Long-term parenteral nutrition in vascular-induced short bowel syndrome].

Authors:  M Gawenda; M Walter
Journal:  Langenbecks Arch Chir       Date:  1996

Review 4.  Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment.

Authors:  Francesca R Ponziani; Maria A Zocco; Chiara Campanale; Emanuele Rinninella; Annalisa Tortora; Luca Di Maurizio; Giuseppe Bombardieri; Raimondo De Cristofaro; Anna M De Gaetano; Raffaele Landolfi; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2010-01-14       Impact factor: 5.742

5.  Recommended timing for surveillance ultrasonography to diagnose portal splenic vein thrombosis after laparoscopic splenectomy.

Authors:  Tung Tran; Sebastian V Demyttenaere; Gerry Polyhronopoulos; Chantal Séguin; Giovanni P Artho; Pepa Kaneva; Gerald M Fried; Liane S Feldman
Journal:  Surg Endosc       Date:  2009-12-29       Impact factor: 4.584

6.  High incidence of hepatitis B infection-associated cirrhosis and hepatocellular carcinoma in the Southeast Asian patients with portal vein thrombosis.

Authors:  Korn Lertpipopmetha; Chirayu U Auewarakul
Journal:  BMC Gastroenterol       Date:  2011-06-10       Impact factor: 3.067

7.  Portal vein thrombosis.

Authors:  Ronny Cohen; Thierry Mallet; Michael Gale; Remigiusz Soltys; Pablo Loarte
Journal:  Case Rep Vasc Med       Date:  2015-02-23

8.  Clinical study of transjugular intrahepatic portosystemic shunt combined with AngioJet thrombectomy for acute portal vein thrombosis in non-cirrhosis.

Authors:  Zhaonan Li; Wenguang Zhang; De-Chao Jiao; Xueliang Zhou; Pengli Zhou; Guangyan Si; Xinwei Han
Journal:  Medicine (Baltimore)       Date:  2021-02-12       Impact factor: 1.817

9.  Nomogram for predicting transmural bowel infarction in patients with acute superior mesenteric venous thrombosis.

Authors:  Meng Jiang; Chang-Li Li; Chun-Qiu Pan; Wen-Zhi Lv; Yu-Fei Ren; Xin-Wu Cui; Christoph F Dietrich
Journal:  World J Gastroenterol       Date:  2020-07-14       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.